Stock-Based Compensation - Schedule of RSU Activity (Details) - $ / shares shares in Thousands |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Weighted Average Grant Date Fair Value | |||
| Granted (in dollars per share) | $ 11.45 | $ 11.45 | $ 0.85 |
| Restricted stock units ("RSUs") | |||
| Shares | |||
| Beginning balance (in shares) | 897 | ||
| Granted (in shares) | 2,430 | ||
| Canceled (in shares) | (17) | ||
| Ending balance (in shares) | 3,310 | 3,310 | |
| Weighted Average Grant Date Fair Value | |||
| Beginning balance (in dollars per share) | $ 1.09 | ||
| Granted (in dollars per share) | 5.57 | ||
| Canceled (in dollars per share) | 2.44 | ||
| Ending balance (in dollars per share) | $ 4.37 | $ 4.37 | |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|